Association of pain and quality of life (QOL) response with PSA response and survival of patients (pts) with metastatic hormone refractory prostate cancer (mHRPC) treated with docetaxel or mitoxantrone in the TAX-327 study. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Berthold, DR
  • Pond, Gregory
  • De Wit, R
  • Eisenberger, MA
  • Tannock, IF

publication date

  • June 20, 2006